The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Abbvie Limited .

Filed returns
59
match these filters
Matching filed returns per period 0 2 5 7 10 Sep–Dec 2015: 1 filed returns May–Aug 2016: 1 filed returns Sep–Dec 2016: 1 filed returns Jan–Apr 2017: 2 filed returns May–Aug 2017: 1 filed returns Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 3 filed returns Jan–Apr 2019: 5 filed returns May–Aug 2019: 7 filed returns Sep–Dec 2019: 9 filed returns Jan–Apr 2020: 1 filed returns May–Aug 2020: 2 filed returns Sep–Dec 2020: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 2 filed returns May–Aug 2022: 1 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 2 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 1 filed returns May–Aug 2026: 5 filed returns 2017 2018 2019 2020 2021 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2018 Abbvie Limited Economic Development and Industry To present Abbvies concerns to a proposed change in intellectual property ( IP) legislation that would introduce a Special Protection Certificate (SPC) Waiver (Legislation) 2 On lobbying.ie
Jan–Apr 2018 Abbvie Limited Health To highlight the delays in patients getting access to new innovative medicines and ask for a national policy on access to medicines that will improve Ireland's ranking relative to other European countries (Public policy or programme) 11 On lobbying.ie
Sep–Dec 2017 Abbvie Limited Health To brief TD's on how Ireland is falling behind other countries in Europe on speed of access to new medicines (Public policy or programme) 7 On lobbying.ie
May–Aug 2017 Abbvie Limited Health To update on the operation of the IPHA agreement and policy on access to medicines and deliver our position on Biosimilar Policy. To brief on the work Abbvie are doing in promoting the uptake of STEM subjects (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2017 Abbvie Limited Health To update on the operations of the IPHA agreement and policy on access to new medicine and deliver our position on the new Biosimilar Policy (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2017 Abbvie Limited Health To discuss the operation of the IPHA agreement and policy on access to new innovative medicines (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2016 Abbvie Limited Health To discuss the Fianna Fail Private Members Bill to amend the Health (Pricing and Supply of Medical Goods) Bill 2015 (Legislation) 1 On lobbying.ie
May–Aug 2016 Abbvie Limited Health To communicate the value to the State of securing a successor supply agreement with the Irish Pharmaceutical Healthcare Association (IPHA) (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2015 Abbvie Limited Health Briefing re health sciences research in Ireland and the prominent global role Ireland can play, (Public policy or programme) 2 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 50 84.7%
Economic Development and Industry 5 8.5%
EU Affairs 1 1.7%
Energy and Natural Resources 1 1.7%
Environment 1 1.7%
Taxation 1 1.7%